Why Do Some People Become Addicted While Others Don’t?

Addiction develops through a collision of genetic predisposition, brain chemistry, life experience, and timing, which is why two people can try the same substance and walk away with radically different outcomes. Twin studies consistently estimate that genes account for roughly 40 to 70 percent of a person’s vulnerability, depending on the substance. But that leaves a wide margin for everything else: the neighborhood you grew up in, the age you first experimented, how your body metabolizes a drug, and whether you were already struggling with anxiety or depression. No single factor is destiny, and understanding why some people are more susceptible than others requires looking at how all these threads weave together.

The Genetic Piece Is Large but Not Deterministic

The most reliable way scientists estimate how much genes matter is by comparing identical twins (who share all their DNA) with fraternal twins (who share about half). When identical twins are more likely to both develop addiction than fraternal twins, the difference points to genetic influence. Across dozens of these studies, heritability estimates for substance use disorders land between 0.30 and 0.70, meaning genes explain somewhere between a third and more than two-thirds of the variation in risk.¹ The range depends on the substance: nicotine dependence runs about 33 to 71 percent heritable, alcohol dependence about 48 to 66 percent, cocaine about 42 to 79 percent, and cannabis around 51 to 59 percent.²

Those numbers can sound alarming if you have addiction in your family, but they describe population-level tendencies, not individual fate. No single “addiction gene” has been found. Instead, hundreds or thousands of small genetic variants each nudge risk up or down slightly. Researchers have tried to combine these into polygenic scores that predict someone’s overall genetic susceptibility, but so far those scores explain only about 2 to 10 percent of the variation in who actually develops a substance use disorder.³ A family history of addiction, it turns out, is still a better predictor than any current genetic test: in one longitudinal twin study, family history measures were consistently stronger predictors of adolescent and young-adult substance use than polygenic scores were.⁴

How Dopamine and Brain Chemistry Tilt the Playing Field

Dopamine is often called the “pleasure chemical,” but it is really more of a motivation and salience signal. Your brain releases it when something important happens, whether that thing is food, sex, social connection, or a drug. People differ in how much baseline dopamine activity they have, and that matters. Research using brain imaging has shown that people who develop addictions tend to have lower levels of a particular dopamine receptor, called D2, in the brain’s reward-processing region. Lower D2 receptor availability is linked to higher impulsivity, and impulsivity in turn predicts whether someone will keep using a drug once they start.⁵

An elegant primate study showed how powerfully social circumstances can reshape this biology. When monkeys were housed individually, their dopamine systems looked similar. But once they were placed in social groups, the animals that became socially dominant showed increases in D2 receptors, while subordinate monkeys did not. When given the chance to self-administer cocaine, the subordinate monkeys used it readily; the dominant ones did not.⁶ The takeaway is striking: the same animals had the same brains going in, but their social environment literally changed their neurochemistry in ways that predicted whether they would seek cocaine. In humans the picture is messier, but the principle holds. Your dopamine system is not fixed at birth; it is shaped by experience, status, and stress.

Beyond dopamine, the brain’s stress system plays its own role. A molecule called corticotropin-releasing factor (CRF) ramps up during withdrawal and chronic stress, and it has been identified as a driver of relapse, essentially fueling the compulsive, “dark side” of addiction where a person uses not to feel good but to stop feeling bad.⁷ People whose stress-response systems are already dysregulated, whether from genetics or life experience, may be especially vulnerable to this cycle.

Childhood Adversity and How Environments Get Under the Skin

If genes load the gun, environment often pulls the trigger. Childhood maltreatment is one of the strongest environmental risk factors for developing alcohol and other substance use disorders, and the relationship is not just psychological. Studies of people with alcohol dependence and a history of childhood abuse have found measurable changes in the body’s stress-hormone system, particularly the axis that governs cortisol production.⁸ In other words, early adversity does not merely create painful memories; it recalibrates the body’s stress machinery, leaving it primed for the kind of relief that substances can temporarily provide.

Broader social stressors add another layer. A review of social determinants of health and substance use found that chronic exposure to racism, discrimination, and “socially toxic” environments contributes to both individual and population-level vulnerability to substance use disorders.⁹ Economic circumstances matter too, though in more nuanced ways than people assume. Among students in one European study, low family socioeconomic status was significantly associated with more frequent cannabis use but not with one-time experimentation.¹⁰ Meanwhile, a U.S. study found that young adults from the highest-income families were actually the most likely to use alcohol and marijuana, even though smoking tracked with lower childhood socioeconomic status.¹¹ The upshot is that poverty can drive heavier and more harmful patterns of use, but wealth does not protect against initial exposure. Different substances follow different socioeconomic gradients.

Epigenetics and the Bridge Between Genes and Experience

One of the more fascinating developments in addiction science is the recognition that environmental exposures can chemically modify how genes are expressed without changing the DNA sequence itself. These modifications, often involving small chemical tags attached to DNA, are called epigenetic changes. They help explain how life events can get “biologically embedded,” turning gene activity up or down in ways that persist over time.¹²

A particularly striking example comes from a study that tracked children from before birth into adolescence. Researchers found that a mother’s smoking during pregnancy was associated with specific DNA methylation patterns in the child, and those patterns were in turn linked to higher substance use in adolescence. The indirect path from maternal smoking to the child’s substance use, running through these epigenetic markers, was statistically significant even after the researchers accounted for other prenatal exposures.¹³ This does not mean the children were doomed; it means they started with a slightly different biological baseline, one more responsive to the cues that drive substance use. Epigenetics is still a young field, but it offers a concrete mechanism for how parental and prenatal environments can nudge a child’s addiction risk years before that child ever encounters a drug.

The Adolescent Brain and Timing of First Use

Ask any addiction researcher when people are most vulnerable, and they will point to adolescence. The teenage brain is going through a developmental phase marked by heightened reward sensitivity. The brain region that processes reward, the striatum, responds more intensely to pleasurable stimuli during this period than it does in childhood or adulthood. At the same time, the prefrontal cortex, which handles impulse control and long-term planning, is still maturing and will not fully come online until the mid-twenties. That gap between a revved-up accelerator and underdeveloped brakes creates a window of particular vulnerability.

Neuroimaging studies support this at the level of brain circuitry. Adolescents who go on to develop substance use problems tend to show blunted activation in prefrontal areas during tasks that require stopping an impulsive response, and this pattern appears before heavy substance use begins, suggesting it is a risk factor rather than a consequence.¹⁴ A separate study comparing adolescents with substance use disorders to their unaffected siblings found that both groups showed certain brain connectivity patterns distinct from healthy controls, hinting that some neural signatures of risk are familial and present even in siblings who have not developed problems.¹⁵

Personality Traits That Raise or Lower Risk

Two personality characteristics come up repeatedly in addiction research: impulsivity and sensation-seeking. They sound similar but play different roles. Sensation-seeking, the desire for novel and intense experiences, is more strongly linked to trying drugs in the first place. Impulsivity, the difficulty in inhibiting a response or delaying gratification, is more closely associated with the transition from use to dependence.¹⁶ That same study examined siblings of people addicted to stimulants and found that the siblings also scored high on impulsivity, supporting the idea that impulsivity is a heritable trait that predisposes to dependence. The siblings scored relatively low on sensation-seeking, which may have kept them from experimenting in the first place and thus protected them despite their underlying impulsive tendencies.

Longitudinal research tracking people from adolescence into young adulthood confirms the pattern. Frequent sensation-seeking and involvement in antisocial activities during the teenage years were among the strongest predictors of continued marijuana use and illicit substance use in young adulthood.¹⁷ Closely related is a trait researchers call novelty-seeking: a drive toward new experiences that, in both human and animal studies, predicts not just initiation of drug use but also the transition to compulsive use and a propensity toward relapse across multiple substances.¹⁸

Mental Health and the Self-Medication Trap

People often wonder whether mental illness causes addiction or addiction causes mental illness. The honest answer is both, in a cycle that feeds itself. But the “self-medication hypothesis” captures something real about how the cycle begins for many people. The core idea is that individuals who struggle with painful emotions, whether from depression, anxiety, trauma, or emotional numbness, discover that certain substances provide temporary relief. The relief is not random: people tend to gravitate toward the class of drug that addresses their specific distress.¹⁹

ADHD offers a concrete example. Adults with untreated ADHD have high co-occurrence rates with cocaine use disorder. Brain imaging research has found neurobiological evidence that people with both conditions may experience short-term cognitive benefits from cocaine, essentially compensating for the dopamine deficiency that underlies their attention problems.²⁰ The tragedy is that the “medication” brings its own devastating consequences, but from the brain’s perspective, the initial logic makes sense. Understanding this helps explain why treating underlying mental health conditions is one of the most effective strategies for reducing addiction risk.

Sex Differences in Vulnerability

Men are more likely to use most substances in the first place, but the research increasingly shows that once women begin using, they can progress to addiction faster, a pattern sometimes called “telescoping.” A significant part of this appears to be hormonal. The hormone estradiol, which fluctuates across the menstrual cycle, interacts with the dopamine system in ways that increase motivation to seek psychostimulants and enhance the value of drug-related cues. In animal models, repeated exposure to psychostimulants produces greater incentive sensitization in females than in males.²¹

Research on cocaine specifically has found that females require lower doses to develop preference for the drug and to show psychomotor sensitization. Estradiol generally facilitates cocaine responses in females, while progesterone tends to inhibit them. In males, interestingly, estradiol may actually be protective against drug preference.²² These findings are largely from animal models and should be applied cautiously to humans, where social and cultural factors layer on top of biology. Still, they help explain why addiction treatment programs increasingly recognize that men and women may need different approaches.

The Built-In Protection of Alcohol Metabolism Genes

One of the clearest examples of genetics shaping addiction risk comes from the enzymes that break down alcohol. Alcohol is metabolized in two steps: first it is converted to a toxic intermediate called acetaldehyde, then acetaldehyde is broken down into harmless acetate. Some people carry gene variants that speed up the first step or slow down the second, both of which cause acetaldehyde to accumulate. The result is deeply unpleasant: facial flushing, nausea, rapid heartbeat, and headache. Unsurprisingly, people who experience this reaction tend to drink less and are significantly less likely to develop alcohol dependence.²³

The most dramatic version of this protection comes from a variant of the ALDH2 gene common among people of East Asian descent. People who carry two copies of the inactive variant (homozygotes) experience such severe reactions that they are essentially fully protected against alcoholism, with no such individuals found among alcoholics in one major study. Even carrying one copy of the variant, combined with other protective gene variants in the alcohol-processing pathway, reduced the odds of alcoholism dramatically.²⁴ This is arguably the most straightforward case in all of addiction genetics: a built-in aversive response that makes heavy drinking so physically punishing that dependence rarely develops. No comparable metabolic “shield” has been identified for other drugs, which is part of why protective factors for stimulant or opioid addiction are harder to pin down.

Why Parental Monitoring Works as a Protective Factor

On the environmental side, one of the most well-supported protective factors is parental monitoring, meaning how much a parent knows about where their child is, who they are with, and what they are doing. A recent meta-analysis found a consistent inverse association between parental monitoring and substance use in adolescents and emerging adults. The analysis also identified a bidirectional relationship: better monitoring predicted less substance use, and less substance use predicted continued monitoring. The researchers concluded that promoting parental knowledge and encouraging adolescents to voluntarily share information about their activities, particularly in mid-adolescence, is one of the most promising strategies for limiting young people’s substance use.²⁵ The nuance is that surveillance-style monitoring often backfires; what matters more is a relationship where the teenager feels comfortable disclosing, which is a different and harder thing to cultivate.

An Evolutionary Mismatch

From an evolutionary standpoint, the brain’s reward system did not evolve to handle purified drugs delivered in concentrated doses. It evolved to motivate behaviors that kept our ancestors alive: eating calorie-dense food, forming social bonds, exploring new territory. One perspective holds that addiction is essentially a mismatch between ancient brain circuits and a modern environment flooded with substances that hijack those circuits far more powerfully than any natural reward could.²⁶ Others argue the mismatch story is incomplete, pointing to evidence that humans have been consuming psychoactive plants for millions of years, suggesting a long coevolutionary relationship between our species and mind-altering substances.²⁷

Both perspectives help explain why some people are more vulnerable. If the reward system evolved for a world of scarcity, individuals with especially responsive reward circuits may have had an ancestral advantage in seeking calories and mates. In a modern world with easy access to concentrated substances, that same responsiveness becomes a liability. The variation we see in addiction risk may partly reflect normal genetic variation in reward sensitivity that served different functions in ancestral environments.

The Gut as a New Frontier

One of the more surprising developments in addiction research is the emerging role of the gut microbiome. Scientists have begun to recognize that drug addiction is not purely a brain disorder; the trillions of microorganisms living in your intestines communicate with the brain via hormonal, immune, and neural pathways, and there is growing evidence that the composition of this microbial community can influence vulnerability to addictive behaviors.²⁸ This research is still in its early stages, and no one is suggesting a probiotic cure for addiction. But the gut-brain axis may help explain some of the unexplained variance in who develops substance use problems, particularly given the known links between the microbiome, stress reactivity, and inflammation. It is a reminder that the question of why some people become addicted is not close to being fully answered, and the map of contributing factors keeps getting larger.